Staff reviewed
REQUEST FOR INFORMATION, TRAINING AND CARE DELIVERY MODELS FOR SAFE ADMINISTRATION OF POTENTIAL FDA-APPROVED PSYCHEDELIC THERAPIES IN AMBULATORY CLINICAL SETTINGS
— STAFF
Nothing a clinician does changes on Monday — an RFI collects comment and binds no one — but this is the earliest visible point of a federal effort to define what supervised administration, monitoring and practitioner training for psychedelic therapy will require, which is where a future standard of care and the associated liability exposure will be set. Readers with a view on supervision requirements in ambulatory settings have a comment window; readers without one should note the direction of travel.